EchoMeasure

by iCardio.ai  · Based in United States → — Ultrasound, automated.
Cardiology

Paid
Regulatory Status Disclosed

Overview

EchoMeasure by iCardio.ai is an FDA 510(k) cleared artificial intelligence software designed to automate and enhance the interpretation of cardiac ultrasound images. It processes previously acquired DICOM-compliant transthoracic cardiac ultrasound images, providing automated view classification, image quality assessment, and precise estimation of numerous cardiac anatomical measurements and quantities.

The software aims to support qualified cardiologists, sonographers, and other licensed professional healthcare practitioners in clinical decision-making, aiding diagnostic review, analysis of echocardiographic data, patient record management, and reporting. By automating standard linear and volumetric measurements, EchoMeasure helps minimize intra-reader variability and improve efficiency and accuracy in echocardiographic analysis.

EchoMeasure integrates seamlessly into existing reporting workflows and can be deployed on a secure cloud server or on-premise server. It features a native browser interface for reviewing report summaries, 2D images, and cine loops, with functionality to download reports in PDF format.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Automated processing of DICOM-compliant cardiac ultrasound images
  • Automated view classification and image quality assessment
  • Automated estimation of over a dozen cardiac measurements (linear and volumetric)
  • Automated preliminary report generation in PDF format
  • Machine learning-based view detection, key frame selection, and segmentation
  • Browser interface for reviewing reports, 2D images, and cine loops
  • API for seamless integration with third-party software and hardware
  • Support for clinical decision-making and diagnostic review
  • Tools for organizing and displaying quantitative cardiovascular image data
  • Indicated for use in adult patients

Use Cases

  • Automating echocardiographic interpretation and preliminary reporting
  • Assisting cardiologists and sonographers in clinical decision-making
  • Reducing intra-reader variability and improving consistency in echo reads
  • Increasing efficiency and accuracy of echocardiographic analysis
  • Integration with point-of-care ultrasound (POCUS) devices for enhanced access and quality
  • Streamlining patient record management and reporting workflows

What Physicians Need to Know

Echocardiography AI Features
EchoMeasure is an FDA 510(k)-cleared software that automates over a dozen standard linear and volumetric measurements of the heart from echocardiograms, including Left Ventricular Ejection Fraction (LVEF) using Simpson's Biplane method. It also performs automated view classification and quality checks of images. The software aims to minimize variability in quantitative interpretation of echocardiography and has shown superiority over human readers in ejection fraction estimation. EchoMeasure is designed to integrate into standard reporting workflows and can process DICOM-compliant transthoracic cardiac ultrasound images. iCardio.ai also offers CardioVision, an FDA-cleared AI software that aids in detecting Aortic Stenosis from a single parasternal long axis clip. Other features include EchoCheck for image quality and view classification, real-time feature labeling for edge devices, and EchoGPT for image-to-text descriptions of ultrasound images.
AHA/ACC Guideline Alignment
While direct statements about AHA/ACC guideline alignment for EchoMeasure are not explicitly detailed, iCardio.ai's CEO has scientific publications and abstract presentations at ASE (The American Society of Echocardiography) and ACC (American College of Cardiology), indicating engagement with leading cardiology organizations.
Cardiac Monitoring Integration
EchoMeasure is designed to integrate with existing systems. It is delivered via API and through PACS and ultrasound-hardware partners. iCardio.ai has partnerships with UltraLinQ, Butterfly Network, and GE HealthCare for integration.
Physician Tip

EchoMeasure can significantly reduce the time spent on manual echocardiogram measurements, potentially decreasing sonographer workload and the risk of work-related musculoskeletal disorders. The automated measurements and quality checks can enhance consistency and accuracy in echo interpretation, which is particularly valuable in busy clinical settings. The integration with PACS and ultrasound hardware allows for a streamlined workflow, making AI-powered analysis readily available within existing systems. Physicians should review and validate the AI-generated measurements and reports, as the software is intended as an aid for clinical decision-making.

EchoMeasure is designed for integration into existing healthcare IT infrastructure. It is available via API and through partnerships with PACS and ultrasound hardware vendors. Current integrations include UltraLinQ, with planned integrations with Butterfly Network and GE HealthCare. This allows for seamless incorporation into current echocardiography workflows.

Details

Category Cardiology AI
Pricing Paid
DeploymentCloud-based; On-premise server
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Cardiology

What the Web Says

EchoMeasure, developed by iCardio.ai, is an FDA-cleared AI software designed to automate the analysis of cardiac ultrasound images, specifically transthoracic echocardiography. It provides automated measurements, view classification, and image quality assessment, aiming to enhance diagnostic accuracy and efficiency for clinicians. The software integrates into existing cardiac imaging workflows and generates preliminary reports for review by qualified healthcare professionals.

Overall: Positive

Strengths

  • Automates echocardiography measurements and analysis, reducing manual calculation time.
  • Aims to improve accuracy and consistency by reducing human error and inter-observer variability.
  • Integrates into existing cardiac imaging and reporting workflows, streamlining the process.
  • Frees up cardiologists and sonographers to focus on interpretation and patient care.
  • Helps healthcare facilities handle larger volumes of cardiac studies without proportionally increasing staffing.
  • FDA 510(k) cleared, indicating it meets regulatory standards for medical devices.

Limitations

  • Limited public reviews from physicians, healthcare IT, or tech reviewers specifically for EchoMeasure by iCardio.ai were found.
  • No specific reviews or discussions about EchoMeasure were found on Reddit, G2, or Capterra.
  • Potential challenges with AI tools in echocardiography include accuracy concerns, training requirements, and trust in the technology.
  • The output from EchoMeasure is intended to aid diagnostic review and analysis, and the final decision rests with the reviewing clinician.

Based on reviews from: medaxiom.com, fda.gov, healthcareaiops.com, roddenberryprize.org, icardio.ai, saashub.com, cardiacwire.com, physicianaitools.com, reddit.com, substack.com, g2.com

Last updated: 2026-10-30

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate EchoMeasure

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

icardio.ai
iCardio.ai EchoMeasure™ and CardioVision™ are FDA 510(k) cleared
iCardio.ai's EchoMeasure and CardioVision products have received FDA 510(k) clearance, enabling robust ultrasound imaging workflows, including image classification, quality assessment, and various cardiac measurement estimations.
2026-01
icardio.ai
iCardio.ai Receives Second FDA 510(k) Clearance, CardioVision™ for Aortic Stenosis
iCardio.ai announced its second FDA 510(k) clearance for CardioVision™, an artificial intelligence software designed for the interpretation of aortic stenosis on echocardiography.
2025-11
medaxiom.com
HeartX Success Story: iCardio.ai
iCardio.ai, a Los Angeles-based company, is advancing machine learning and deep learning algorithms for ultrasound, with a focus on transthoracic echocardiography. Their flagship product, EchoMeasure™, recently received U.S. Food and Drug Administration (FDA) 510(k) clearance, providing clinicians with an automated, comprehensive imaging workflow and preliminary reporting tool.
2025-04
covefund.com
iCardio.ai Closes $4.5M Strategic Financing Led by Cedars-Sinai
iCardio.ai secured $4.5 million in strategic financing led by Cedars-Sinai, aiming to advance echocardiography through artificial intelligence and gain access to Cedars-Sinai's extensive cardiac imaging dataset.
2026-04
cardiovascularbusiness.com
FDA approves AI startup's new software for echo assessments
iCardio.ai, co-founded by a cardiologist, received FDA approval for its EchoMeasure software, which evaluates echocardiography data and is the company's first FDA approval.
2024-10
viz.ai
Viz.ai Partners with iCardio.ai to Accelerate Aortic Stenosis Detection and Improve Patient Outcomes
Viz.ai announced a partnership with iCardio.ai to enhance the rapid detection of aortic stenosis and facilitate patient triage through the integration of iCardio.ai's ultrasound interpretation technology into Viz.ai's care coordination solution.
2024-04
fda.gov
510(k) Premarket Notification K241430
The FDA granted 510(k) clearance to iCardio.ai's EchoMeasure, a software device for processing DICOM-compliant transthoracic cardiac ultrasound images, providing automated view classification, quality checks, and cardiac measurements.
2024-10
asecho.org
Congratulations to the Winner of the 2026 Shark Tank Innovation Competition: iCardio.ai!
iCardio.ai won the 2026 Shark Tank Innovation Competition at ASE's Scientific Sessions, recognized for its clear progress and development roadmap for translating technology innovations into a sustainable business model, with EchoMeasure as its flagship product.
2026-06

Videos

Product demos, reviews, and walkthroughs for EchoMeasure.

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

EchoMeasure can automate over a dozen standard linear and volumetric measurements of the heart, including Left Ventricular Diastolic Diameter (LVDd), Left Ventricular Systolic Diameter (LVSd), Right Ventricular Diastolic Diameter (RVDd), Right Ventricular Systolic Diameter (RVSd), Left Atrial Dimension (LAd), Posterior Wall Thickness (PWd), Interventricular Septal Thickness (IVSd), Left Ventricular Outflow Tract Diameter (LVOTd), Diameter of the Aortic Annulus (AAd), Diameter of the Sinus of Valsalva (SoVd), Diameter of the Sinotubular Junction (StJd), Left Ventricular Ejection Fraction (LVEF) using Simpson's Biplane method, Left Ventricular Diastolic Area (LVDa), and Left Ventricular Systolic Area (LVSa).
EchoMeasure is FDA 510(k) cleared, indicating it meets regulatory standards for medical devices. The software is designed to process previously acquired DICOM-compliant cardiac ultrasound images, and the data produced is intended to support qualified healthcare practitioners for clinical decision-making. While specific details on data security protocols for EchoMeasure are not explicitly detailed, medical device integrations with EMR/EHR systems generally require adherence to standards like HIPAA for data protection and security.
EchoMeasure is intended to support qualified clinicians in decision-making, meaning human oversight is still required. While AI can improve efficiency and accuracy, echocardiography itself has limitations related to patient body habitus, technical aspects of the scan, and specific clinical questions it isn't designed to answer, such as reliably imaging coronary arteries. The accuracy of any AI model also depends on the quality and consistency of the data used to train and validate it.
EchoMeasure is designed to be seamlessly integrated into the standard reporting workflow. The output from EchoMeasure is intended for consumption by third-party software and hardware vendors, and it also offers a native browser interface for reviewing report summaries and downloading PDF reports. Generally, medical device integration with EMR systems aims to streamline workflows, reduce manual charting, and improve data accuracy by automating the transfer of patient data.
Yes, the field of AI in echocardiography is advancing rapidly, with other AI-powered tools available. For example, Ultromics offers EchoGo, which provides automated measurements of left ventricular volumes, ejection fraction, and cardiac strain. Us2.ai also provides FDA-cleared AI echocardiography reporting software for automated analysis. Research also highlights other AI frameworks that integrate echocardiographic images and EMR data for enhanced heart disease screening.

Related Tools

EchoMD AutoEF
Caption Health (formerly Bay Labs, now part of GE HealthCare)
Cardiology AI
EchoMD AutoEF is an FDA-cleared AI software that automates the selection of echocardiogram clips and calculates left ventricular ejection fraction (EF), enhancing efficiency and accuracy in cardiac assessments.
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
Cardiology AI
An AI software platform for coronary plaque analysis and quantification from CT angiography.
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.
syngo.CT Coronary Cockpit
Siemens Healthineers
Cardiology AI
syngo.CT Coronary Cockpit is an AI-powered software tool by Siemens Healthineers for efficient and accurate CT coronary angiography analysis.
HeartLung AI-CVD®
HeartLung Corporation
Cardiology AI
HeartLung AI-CVD® is an FDA-cleared AI-powered quantitative imaging tool that provides automated CT-derived measurements for assessing cardiovascular and multisystem risks opportunistically.

See all Cardiology AI tools →

More from iCardio.ai

CardioVision
Icardio.Ai
Cardiology AI
CardioVision by iCardio.ai is an FDA-cleared AI software that provides adjunctive diagnostic support for detecting moderate to severe aortic stenosis from echocardiogram images, streamlining cardiovascular diagnostics.
iCardio.ai
iCardio.ai
Cardiology AI
iCardio.ai provides FDA-cleared AI software for automated echocardiographic interpretation, offering automated measurements, disease detection (e.g., aortic stenosis), and image quality assessment to streamline cardiac diagnostics.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.